ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,728.80
0.41%
US Tech 100
19,528.00
0.90%
Dow Jones
42,052.19
0.69%
Brent Oil
72.905
0.00%
Bitcoin
68,504.45
-1.16%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. UK
  5. LSE

  6. Hsbc Eur Exuksu (HSXU) Quote

Hsbc Eur Exuksu

Hsbc Eur Exuksu (HSXU)

LSE
16.817
0.192
(1.15%)
Closed November 03 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
16.817
Bid
16.788
Ask
16.846
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
323.941B
Previous Close
16.625
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
19,262,728,000
Dividend Yield
-
PE Ratio
26.01
Earnings Per Share (EPS)
1.22
Revenue
65.91B
Net Profit
23.53B

About Hsbc Eur Exuksu

Sector
Offices-bank Holding Company
Industry
Offices-bank Holding Company
Website
www.hsbc.com
Headquarters
London, Gbr
Founded
-
Hsbc Eur Exuksu is listed in the Offices-bank Holding Company sector of the London Stock Exchange with ticker HSXU. The last closing price for Hsbc Eur Exuksu was $16.63. Over the last year, Hsbc Eur Exuksu shares have traded in a share price range of $ 0.00 to $ 0.00.

Hsbc Eur Exuksu currently has 19,262,728,000 shares outstanding. The market capitalization of Hsbc Eur Exuksu is $320.24 billion. Hsbc Eur Exuksu has a price to earnings ratio (PE ratio) of 26.01.

HSXU Latest News

More News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 01 November 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

November 01 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 01 November 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

November 01 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 30 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 30 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 29 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 29 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 28 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 28 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 25 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 25 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 24 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 24 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 23 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 23 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 22 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 22 2024
RNS Regulatory News

HSBC ETFs Europe Ex UK Sus Equity $ Net Asset Value(s)

HSBC ETFs Europe Ex UK Sus Equity $ 21 October 2024   Fund: HSBC EUROPE EX UK SUST EQUITY UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous Valuation...

October 21 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VSTEVast Renewable Ltd
$ 4.98
(149.00%)
68.46M
INVZWInnoviz Technologies Ltd
$ 0.096
(96.71%)
22.71k
CDXCChromaDex Corporation
$ 5.87
(68.19%)
37.58M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
236.07M
TILEInterface Inc
$ 23.24
(33.03%)
2.12M
EPIXESSA Pharma Inc
$ 1.45
(-72.12%)
33.85M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
201.61M
OSTOstin Technology Group Company Ltd
$ 0.275
(-45.00%)
2.27M
LXRXLexicon Pharmaceuticals Inc
$ 1.23
(-36.92%)
19.96M
VCIGVCI Global Ltd
$ 0.0583
(-27.58%)
26.13M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
236.07M
SQQQProShares UltraPro Short QQQ
$ 7.44
(-2.11%)
214.96M
NVDANVIDIA Corporation
$ 135.40
(1.99%)
206.38M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
201.61M
INTCIntel Corporation
$ 23.20
(7.81%)
171.4M

Discussion

View Full Feed
blackhawks blackhawks 13 seconds ago
From the same article.

It's also worth noting that on Aug. 21, the Labor Department issued a preliminary revision of its data that estimated that the number of manufacturing jobs created over the 12 months ending in March was likely 115,000 lower than the original estimate. The final
100lbStriper 100lbStriper 23 seconds ago
long live strap!!! https://media.stocktwits-cdn.com/api/3/media/194796/default.jpg
NLST
hedge_fun hedge_fun 54 seconds ago
The Great Kentucky Hoard - Part 2…….

[yt]nZ4SWTatvqM[/yt]
EXPL
ohsaycanyousee82 ohsaycanyousee82 1 minute ago
There is a chance (though slim) that Kun Jin is nearly as smart, insightful, knowledgable, adept and gifted about the complexities of biotech analysis as you. And there is a chance that he may nearly have access to as much specific information about Anavex and its compounds as you.

AVXL
BlazingStocks BlazingStocks 1 minute ago
$COEP OUR SCIENCE
Coeptis Therapeutics’ science is built on the notion that cell therapies should be safe, effective, and available for everyone. Recent medical breakthroughs in cell therapy are quickly leading to a renaissance in the treatment of diseases once believed to be untreatable. Coe
COEP
Freddie bagholder Freddie bagholder 2 minutes ago
watch all the rats that abandoned ship come back. Already see some here praying for amish.
FNMA
02opida 02opida 2 minutes ago
BNGRF - Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
02opida 02opida 2 minutes ago
NFE - SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against New Fortress Energy Inc. - NFE
02opida 02opida 2 minutes ago
DUK - Duke Energy responds to constructive Carolinas Resource Plan decision by North Carolina Utilities Commission
DesktopDR DesktopDR 2 minutes ago
I'm going to guess that these nonsense messages come from investors that have been here for a long time. Tired of waiting and angry. People say things out of anger and in time normally wish they hadn't, especially when proven wrong. I wish them well and wish they would stop posting.
VPLM
02opida 02opida 3 minutes ago
NNBR - NN, Inc. Executive Management to Present at the Gabelli Funds 48th Annual Automotive Symposium
100lbStriper 100lbStriper 3 minutes ago
doc 810 https://charts.stocktwits-cdn.com/production/original_591010496.png
NLST
Monterey2000 Monterey2000 3 minutes ago
I am wondering if the stock repurchases actually help to reduce or completely offset any dilution caused by the stock warrants as part of the convertible note transactions as noted in the posts by jealmc79.
IDCC
eyal2 eyal2 3 minutes ago
If this is real answer we have NOTHING.
They feed us with lies and deception,,,!!
MWWC
100lbStriper 100lbStriper 3 minutes ago
doc 811 https://charts.stocktwits-cdn.com/production/original_591010485.png
NLST
EZ2 EZ2 4 minutes ago
Sierra Leone ~~~~ :-)

GM and happy SUNday !!
02opida 02opida 4 minutes ago
AVRW
AVRW
02opida 02opida 4 minutes ago
INBS
INBS
100lbStriper 100lbStriper 4 minutes ago
doc 812 https://charts.stocktwits-cdn.com/production/original_591010480.png
NLST
02opida 02opida 4 minutes ago
UPXI.............................................https://www.stockscores.com/charts/charts/?ticker=UPXI
UPXI
Debunkinator Debunkinator 5 minutes ago
You never know--These words keep popping up in all tweets from Company😎

ASII
@ASII_Inc
#ASII We have been working real hard and excited to share a MAJOR UPDATE MONDAY!
#ACQUISITION #NASDAQ #UPLIST
6:08 AM · Oct 31, 2024
·
8,545
ASII
02opida 02opida 5 minutes ago
DPLS yes, I think we found bottom range
DPLS
biowin biowin 6 minutes ago
Private companies in the United States don't have to disclose their directors like they do in Canada, Bioamber Inc is a US company
02opida 02opida 6 minutes ago
SNNC
SNNC

Your Recent History

LSE
HSXU
Hsbc Eur Exuksu
NASDAQ
DYNI
IDX Dynamic Innovation ETF
USOTC
TXCB
Cang Bao Tian Xia Intern... (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved